Dashboard
Manage Tickers

XCUR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
10/24/2025 21:06:06

exicure-says-ongoing-phase-2-study-of-burixafor-in-autologous-stem-cell-transplant-for-multiple-myeloma-nears-key-readout
Exicure Says Ongoing Phase 2 Study Of Buri...
10/06/2025 11:04:39

Burixafor Phase 2 Trial in Multiple Myeloma Nears Key Clinical ReadoutExicure's ongoing Phase 2 study (NCT05561751) is a ra...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 21:06:02

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 17:06:18

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
08/11/2025 12:08:21

exicure-says-management-believes-that-the-companys-existing-cash-and-cash-equivalents-is-not-sufficient-to-continue-to-fund-operations-says-substantial-additional-financing-is-needed-in-short-term
Exicure Says 'Management believes that the...
08/08/2025 20:03:17

exicure-q2-eps-041-down-from-035-yoy
Exicure Q2 EPS $(0.41) Down From $(0.35) YoY
08/08/2025 20:02:16

Exicure (NASDAQ:XCUR) reported quarterly losses of $(0.41) per share. This is a 17.14 percent decrease over losses of $(0.35) p...

exicure-regains-nasdaq-compliance
Exicure Regains Nasdaq Compliance
08/04/2025 20:38:42

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/01/2025 21:06:34

exicure-completes-phase-2-trial-of-gpc-100-for-stem-cell-mobilization-in-multiple-myeloma-topline-results-expected-q4-2025
Exicure Completes Phase 2 Trial Of GPC-100...
08/01/2025 20:03:24

Topline results expected H2 2025Exicure, Inc. (NASDAQ:XCUR), a clinical-stage biotechnology company developing therapeutics for...

exicure-files-for-prospectus-offering-52m-common-stock-offered-by-selling-stockholders
Exicure Files For Prospectus Offering 5.2M...
07/14/2025 15:47:30

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/01/2025 17:05:56

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/01/2025 12:07:35

progress-software-exicure-and-3-stocks-to-watch-heading-into-monday
Progress Software, Exicure And 3 Stocks To...
06/30/2025 08:35:23

U.S. stock futures up, focus on PRGS, XCUR, QMCO earnings. VERO jumps 43.6% after stake increase, IGC reports positive results...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
06/27/2025 21:05:51

exicure-q1-eps-049-up-from-048-yoy
Exicure Q1 EPS $0.49 Up From $(0.48) YoY
06/27/2025 20:02:20

Exicure (NASDAQ:XCUR) reported quarterly earnings of $0.49 per share. This is a 202.08 percent increase over losses of $(0.48) ...

exicure-receives-nasdaq-delinquencyletter-regarding-late-filing-of-its-form-10-q
Exicure Receives Nasdaq DelinquencyLetter ...
05/28/2025 21:00:59

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
04/21/2025 17:05:41

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
04/17/2025 21:05:38

reported-earlier-exicure-nears-completion-of-phase-2-trial-of-gpc-100-in-multiple-myeloma-doses-19th-patient-in-stem-cell-mobilization-study
Reported Earlier, Exicure Nears Completion...
04/15/2025 07:33:37

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION